A synthetic peptide for use as a blocking control in assays to test for specificity of SLCO1 B1 antibody, Alternative Names: SLCO1B1 control peptide, SLCO1B1 antibody Blocking Peptide, Anti-SLCO1B1 Blocking Peptide, solute carrier organic anion transporter family, member 1B1 Blocking Peptide, LST-1 Blocking Peptide, MGC133282 Blocking Peptide, OATP-C Blocking Peptide, OATP1B1 Blocking Peptide, OATP2 Blocking Peptide, SLC21A6 Blocking Peptide, SLCO1B1, SLCOB-1, SLCOB 1, SLCOB-1 Blocking Peptide, SLCOB 1 Blocking Peptide
SLCO1B1
Reaktivität: Human
Wirt: Synthetic
BP, BI
Sodium azide
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
SLCO1B1
(Solute Carrier Organic Anion Transporter Family, Member 1B1 (SLCO1B1))
Hintergrund
This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function.